Microrna-185 Reduces The Expression Of Hepatitis B Virus Surface Antigen By Targeting Prkch In Hepg2 2.2.15 Cells

R Zhang,Z Liu,X Hou,M Wang,Y Xiong,H Lu,Y Wang,J Su,Y Liu,G Zhang,Y Liu
DOI: https://doi.org/10.4149/av_2020_304
2020-01-01
Acta Virologica
Abstract:MicroRNAs (miRNAs) are single-stranded noncoding RNAs with 18 to 25 nucleotides and play critical roles in a wide spectrum of biological processes. We repored that miR-185 inhibited hepatitis B surface antigen (HBsAg) expression and hepatitis B virus (HBV) replication without affecting the proliferation of HepG2 2.2.15 cells, compared with the controls. We identified that protein kinase C eta (PRKCH) is a direct target gene of miR-185 that affects HBV replication and protein expression and that the miR-185 may suppress HBV replication. Our results provide more information for gene therapy in HBV infection.
What problem does this paper attempt to address?